Toth Financial Advisory Corp Abb Vie Inc. Transaction History

Toth Financial Advisory Corp

$825 Million
Q3 2024

A detailed history of Toth Financial Advisory Corp transactions in Abb Vie Inc. stock. As of the latest transaction made, Toth Financial Advisory Corp holds 39,005 shares of ABBV stock, worth $6.64 Million. This represents 0.93% of its overall portfolio holdings.

Number of Shares

39,005

Previous 39,005 -0.0%

Holding current value

$6.64 Million

Previous $6.69 Million 15.13%

% of portfolio

0.93%

Previous 0.86%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	BUY	$154.79 - $180.76 $69,500 - $81,161	449 Added 1.16%	39,005 $6.69 Million
Q1 2024 Apr 16, 2024	SELL	$159.82 - $182.1 $21,096 - $24,037	-132 Reduced 0.34%	38,556 $7.02 Million
Q4 2023 Jan 26, 2024	BUY	$137.6 - $154.97 $21,465 - $24,175	156 Added 0.4%	38,688 $6 Million
Q3 2023 Oct 12, 2023	SELL	$133.59 - $154.65 $422,545 - $489,157	-3,163 Reduced 7.59%	38,532 $5.74 Million
Q2 2023 Jul 24, 2023	SELL	$132.51 - $164.9 $894,707 - $1.11 Million	-6,752 Reduced 13.94%	41,695 $5.62 Million
Q1 2023 Apr 24, 2023	SELL	$144.61 - $166.54 $765,276 - $881,329	-5,292 Reduced 9.85%	48,447 $7.72 Million
Q4 2022 Jan 24, 2023	SELL	$138.31 - $165.87 $394,875 - $473,558	-2,855 Reduced 5.04%	53,739 $0
Q3 2022 Oct 14, 2022	SELL	$134.21 - $153.93 $564,755 - $647,737	-4,208 Reduced 6.92%	56,594 $7.6 Million
Q2 2022 Jul 25, 2022	SELL	$137.62 - $174.96 $2.07 Million - $2.63 Million	-15,036 Reduced 19.83%	60,802 $9.31 Million
Q1 2022 Apr 26, 2022	SELL	$131.98 - $163.75 $1.67 Million - $2.07 Million	-12,647 Reduced 14.29%	75,838 $12.3 Million
Q4 2021 Jan 31, 2022	BUY	$107.43 - $135.93 $567,660 - $718,254	5,284 Added 6.35%	88,485 $12 Million
Q3 2021 Oct 20, 2021	BUY	$106.4 - $120.78 $180,880 - $205,326	1,700 Added 2.09%	83,201 $8.98 Million
Q2 2021 Jul 26, 2021	BUY	$105.21 - $117.21 $99,528 - $110,880	946 Added 1.17%	81,501 $9.18 Million
Q1 2021 Apr 20, 2021	SELL	$102.3 - $112.62 $295,953 - $325,809	-2,893 Reduced 3.47%	80,555 $8.72 Million
Q4 2020 Jan 25, 2021	BUY	$80.49 - $108.67 $712,095 - $961,403	8,847 Added 11.86%	83,448 $8.94 Million
Q3 2020 Oct 16, 2020	SELL	$85.91 - $100.83 $11,683 - $13,712	-136 Reduced 0.18%	74,601 $6.53 Million
Q2 2020 Jul 14, 2020	BUY	$73.37 - $98.18 $1.51 Million - $2.03 Million	20,645 Added 38.17%	74,737 $7.34 Million
Q1 2020 Apr 20, 2020	BUY	$64.5 - $97.79 $632,551 - $959,026	9,807 Added 22.15%	54,092 $4.12 Million
Q4 2019 Jan 27, 2020	SELL	$72.13 - $90.25 $75,447 - $94,401	-1,046 Reduced 2.31%	44,285 $3.92 Million
Q3 2019 Oct 15, 2019	SELL	$62.98 - $75.72 $765,899 - $920,830	-12,161 Reduced 21.15%	45,331 $3.43 Million
Q2 2019 Jul 17, 2019	BUY	$65.7 - $83.98 $127,852 - $163,425	1,946 Added 3.5%	57,492 $4.18 Million
Q1 2019 Apr 15, 2019	SELL	$77.14 - $90.79 $942,882 - $1.11 Million	-12,223 Reduced 18.04%	55,546 $4.48 Million
Q4 2018 Jan 22, 2019	SELL	$77.85 - $96.01 $433,001 - $534,007	-5,562 Reduced 7.58%	67,769 $6.25 Million
Q3 2018 Oct 15, 2018	SELL	$88.91 - $98.84 $58,769 - $65,333	-661 Reduced 0.89%	73,331 $6.94 Million
Q2 2018 Jul 23, 2018	BUY	$89.78 - $106.23 $93,999 - $111,222	1,047 Added 1.44%	73,992 $6.86 Million
Q1 2018 Apr 25, 2018	BUY	$92.01 - $123.21 $13,065 - $17,495	142 Added 0.2%	72,945 $6.9 Million
Q4 2017 Feb 06, 2018	BUY	$89.56 - $98.21 $58,034 - $63,640	648 Added 0.9%	72,803 $7.04 Million
Q3 2017 Oct 11, 2017	BUY	$69.85 - $89.22 $5.04 Million - $6.44 Million	72,155	72,155 $6.41 Million

Others Institutions Holding ABBV

# of Institutions

3,808

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.94M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $301B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Toth Financial Advisory Corp, based on Form 13F filings with the SEC.

News

Stay updated on Toth Financial Advisory Corp with notifications on news.

Account

Toth Financial Advisory Corp Abb Vie Inc. Transaction History